Physician profile
Frank K Yoo
NPI 1295774545
$604,730.53
in general payments reported to CMS, 2019-2025
54 companies · $87K in 2025
The $87K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $75K · 2020: $84K · 2021: $128K · 2022: $6,144 · 2023: $112K · 2024: $112K · 2025: $87K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $206K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $77K · Travel and Lodging: $17K · Consulting Fee: $7,975 · Food and Beverage: $3,362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $206,034.33 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $76,607.00 |
| Travel and Lodging | $17,293.80 |
| Consulting Fee | $7,975.00 |
| Food and Beverage | $3,361.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovasis INC | $551,592.78 | 2019-2025 | Axha, Axha |
| Medyssey USA, INC | $13,219.15 | 2019-2023 | |
| Precision Spine, INC. | $9,051.39 | 2019-2021 | |
| Collagen Matrix, INC | $7,000.00 | 2022-2024 | |
| Centinel Spine, LLC | $6,034.47 | 2020-2023 | Fortos-C, Stalif C-Ti |
| Ctl Medical Corporation | $2,989.74 | 2025 | Raphael Pedicle Screw System |
| The Institute of Musculoskeletal Science and Education | $2,488.10 | 2020-2021 | |
| Kyocera Medical Technologies, INC. | $2,400.00 | 2024 | |
| Surgalign Spine Technologies, INC. | $2,294.18 | 2022 | |
| Abbott Laboratories | $1,187.53 | 2021-2025 | Proclaim, Penta, Eterna |
| Nexxt Spine LLC | $1,162.90 | 2025 | Nexxt Spine Technology, Nexxt Spine Product Portfolio, Matrixx Case Review |
| Spineart USA INC | $773.46 | 2023-2024 | Perla Tl |
| Globus Medical, INC. | $726.91 | 2021-2025 | Reline, Modulus, Senza |
| Solco Biomedical Corporation | $450.00 | 2023-2024 | 4cis Chiron Spinal Fixation System, 4cis Marlin Peek Acif Cage |
| Boston Scientific Corporation | $413.17 | 2021-2025 | Wavewriter Alpha Prime 16 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Camber Spine Technologies LLC | $401.86 | 2019-2021 | |
| Axonics, INC. | $281.73 | 2021 | |
| Medtronic, INC. | $249.97 | 2021-2025 | Intellis Adaptivestim, Mazor X System, Synchromedii |
| Stryker Corporation | $245.21 | 2019-2025 | N/A |
| Kerecis Limited | $226.62 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Si-Bone, INC. | $198.23 | 2021-2025 | |
| Nevro Corp. | $188.04 | 2023 | Senza |
| Carlsmed, INC. | $139.34 | 2024 | Aprevo |
| Acera Surgical, INC. | $119.53 | 2025 | Restrata Wound Matrix |
| Zimmer Biomet Holdings, INC. | $79.00 | 2020-2021 | |
| Livanova USA, INC. | $74.76 | 2022-2025 | Vns Therapy Symmetry Model 8103 Generator |
| Microtransponder, INC. | $72.24 | 2023 | |
| Aegis Spine, INC. | $58.90 | 2021 | |
| Alphatec Spine, INC | $54.20 | 2022-2025 | |
| Intrinsic Therapeutics | $44.43 | 2023 | Barricaid Acd (Annular Closure Device) |
| Arteriocyte Medical Systems, INC. | $36.24 | 2022-2025 | Magellan |
| Spinal Simplicity, LLC | $30.87 | 2023 | Ha Minuteman G3-R |
| Eisai INC. | $30.53 | 2019 | |
| Cerapedics INC. | $28.04 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Pfizer INC. | $26.82 | 2025 | |
| Ethicon US, LLC | $26.65 | 2022 | |
| Monteris Medical Corporation | $26.08 | 2024 | Neuroblate |
| Progenics Pharmaceuticals, INC. | $24.89 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $24.59 | 2024 | Iovera, Exparel |
| Saluda Medical Americas, INC. | $24.50 | 2025 | Evoke |
| Celgene Corporation | $23.53 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $23.35 | 2019 | |
| Mylan Pharmaceuticals INC. | $21.46 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.08 | 2020 | |
| Orthofix Medical, INC. | $19.89 | 2025 | Cove |
| Ceribell, INC. | $19.01 | 2024 | Pocket Eeg Device |
| Blueprint Medicines Corporation | $18.53 | 2020 | |
| Janssen Biotech, INC. | $18.32 | 2019 | |
| Foundation Medicine, INC. | $15.56 | 2019 | |
| Seagen INC. | $14.73 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.75 | 2019 | |
| Medtronic USA, INC. | $13.55 | 2019 | |
| Secura Bio, INC. | $11.72 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,500.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Yoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.